“增健口服液”治疗药物性肝损害的疗效研究  

作　　者：许申[1] 

机构地区：[1]安徽省肺科医院,230022

出　　处：《临床肺科杂志》2001年第3期3-4,共2页Journal of Clinical Pulmonary Medicine

摘　　要：目的　研究增健口服液对抗结核药物治疗过程中产生肝损害的治疗疗效。方法　采用一般保肝治疗 2 2例 ,与加用增健口服液 3 6例对照比较。结果　使用增健口服液后 ,肝功能平均恢复天数明显短于使用一般保肝治疗的病人。Purpose To explore the beneficial effects of 'Health Enhancement Oral Liquid' on the improvement of liver function of tuberculosis patients.Methods Two groups of tuberculosis patients were compared: 22 patients in the regular treatment group and 36 in the 'Health Enhancement Oral Liquid' group.Results By using 'Health Enhancement Oral Liquid,' symptoms of the patients in the 'Health Enhancement Oral Liquid' group have lessened significantly faster than the regular treatment group. The mean length of liver function recovery was significantly shorter in the 'Health Enhancement Oral Liquid' group than in the regular treatment group.Conclusion The use of 'Health Enhancement Oral Liquid' has showed significant beneficial effects on the improvement of liver function of tuberculosis patients.

关 键 词：增健口服液 药物性肝损害 治疗 

分 类 号：R285.6[医药卫生—中药学]